Drugs / PEA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03646552 Background | Jun 2018 → Apr 2019 | obstructive sleep apnea syndrome | Neurothera Labs Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEA | “THX-110 (a combination of Dronabinol and PEA)” NCT03646552 ↗ |